Security key
64130M209
NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock (NMTC)
CUSIP: 64130M209
Q4 2021 13F Holders as of 31 Dec 2021
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 8,477,622
- Total 13F shares
- 1,946,125
- Share change
- +1,634,132
- Total reported value
- $3,774,000
- Price per share
- $1.94
- Number of holders
- 12
- Value change
- +$3,070,716
- Number of buys
- 8
- Number of sells
- 3
Report period
Q4 2021
Institutions
12
Top holders
10
NMTC full security history
Newer quarter: Q1 2022
Previous quarter: Q3 2021
NEUROONE MEDICAL TECHNOLOGIES Corp SEC filings
NEUROONE MEDICAL TECHNOLOGIES Corp company facts
Broader feeds
Reporting periods
Holder history for CUSIP 64130M209
Recent filing periods:
Top shareholders of NMTC - NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1.3%
|
106,151
|
$419,000 | — | 30 Sep 2021 | |
| Intersect Capital LLC |
13F
|
Company |
0.59%
|
50,000
|
$198,000 | — | 30 Sep 2021 | |
| PREMIER ASSET MANAGEMENT LLC |
13F
|
Company |
0.59%
|
50,000
|
$197,000 | — | 30 Sep 2021 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.46%
|
39,175
|
$154,000 | — | 30 Sep 2021 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.06%
|
4,907
|
$20,000 | — | 30 Sep 2021 | |
| Cutler Group LLC / CA |
13F
|
Company |
0.01%
|
500
|
$1,000 | — | 30 Sep 2021 | |
| AWM Investment Company, Inc. |
13F
|
Company |
—
class O/S missing
|
1,000,001
|
$3,950,000 | — | 30 Sep 2021 |
Institutional Holders of NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock (NMTC) as of Q4 2021
As of 31 Dec 2021,
NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock (NMTC) was held by
12 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,946,125 shares.
The largest 10 holders included
Stonepine Capital Management, LLC, AIGH Capital Management LLC, Bleichroeder LP, VANGUARD GROUP INC, Worth Venture Partners, LLC, Eidelman Virant Capital, DRIVE WEALTH MANAGEMENT, LLC, Intersect Capital LLC, Aristides Capital LLC, and NORTHERN TRUST CORP.
This page lists
12
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2021 vs Q3 2021 Across Filers
Q3 2021 holders
6
Q4 2021 holders
12
Holder diff
6
| Investor | Q3 2021 Shares | Q4 2021 Shares | Share Diff | Share Chg % | Q3 2021 Value $ | Q4 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.